Flagship Pioneering Inc. Evelo Biosciences, Inc. Transaction History

Flagship Pioneering Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.46 - $3.55 $40 Million - $97.3 Million	27,397,259 Added 118.96%	50,427,328 $106 Million
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $1.26 Million - $2.42 Million	130,000 Added 0.57%	23,030,069 $246 Million
Q2 2020 Aug 13, 2020	BUY	$3.53 - $6.12 $16.5 Million - $28.6 Million	4,666,666 Added 25.59%	22,900,069 $112 Million
Q2 2018 Aug 07, 2018	BUY	$11.39 - $16.26 $208 Million - $296 Million	18,233,403 New	18,233,403 $215 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

Stay updated on Flagship Pioneering Inc. with notifications on news.